# CQSP in Malawi: Chloroquine and Sulfadoxine-pyrimethamine Efficacy for the Treatment of Malaria in Malawi

> **NCT00125489** · PHASE4 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 210 (—)

## Conditions studied

- Malaria
- Plasmodium Falciparum Malaria

## Interventions

- **DRUG:** chloroquine sulfate
- **DRUG:** sulfadoxine/pyrimethamine

## Key facts

- **NCT ID:** NCT00125489
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** —
- **Final completion:** 2005-12
- **Target enrollment:** 210 (—)
- **Last updated:** 2010-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00125489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00125489, "CQSP in Malawi: Chloroquine and Sulfadoxine-pyrimethamine Efficacy for the Treatment of Malaria in Malawi". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00125489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*